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Purpose: The objective of the study was to investigate the ethyl acetate extract of Morinda morindoides 
(Baker) Milne-Redh (Rubiaceae) (MM-EA) properties against experimental diarrheoa induced by castor 
oil in albino Wistar rats. 
Methods: The ethyl acetate extract of Morinda morindoides (250, 500, and 1000 mg/kg body weight) 
was administered orally to three groups of rats (five animals per group) in order to evaluate the activity 
of the extract against castor oil-induced diarrhea model in rat. Two other groups received normal saline 
(5mg/kg) and loperamide (5mg/kg) as positive control. The effect of the extract on intestinal transit and 
castor oil-induced intestinal fluid accumulation (enteropooling) was assessed. 
Results: At oral doses of 250, 500, and 1000 mg/kg body weight, the plant extract showed pronounced 
and dose-dependent antidiarrheal activity. The protective role of the extract at 1000 mg/kg was 
comparable to that of the reference drug, loperamide (5mg/kg). The extract (1000 mg/kg) produced a 
decrease in intestinal transit comparable to atropine (5mg/kg), and significantly (p<0.01) inhibited castor 
oil-induced enteropooling. No mortality and visible signs of general weakness were observed in the rats 
following the extract administration of up to a dose of 6000 mg/kg. 
Conclusion: The results showed that the extract of M. morindoides has a significant antidiarrheal 
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INTRODUCTION 
 
Diarrheal diseases are a major problem in 
Third World countries and are responsible for 
the death of millions of people each year
1
. 
Diarrheoa is an alteration in normal bowel 
movement and is characterized by an 
increase in the water content, volume, or 
frequency of stools
2
. Plants have long been a 
very important source of new drugs. Many 
plant species have been screened for 
substances with therapeutic activity. 
Medicinal plants are a promising source of 
antidiarrheal drugs
3
. For this reason, 
international organizations including the 
World Health Organization (WHO) have 
encouraged studies pertaining to the 
treatment and prevention of diarrheal 
diseases using traditional medical 
practices
4,5,6
. Morinda morindoides (Baker) 
Milne-Redh (Rubiaceae) is found in the 
borders of tropical forests. In the Democratic 
Republic of Congo, M. morindoides has long 
been used in villages and towns in the 
treatment of some parasitic diseases, and the 
leaf extracts of the plant have been shown to 
possess antiprotozoal activity particularly 
against Entamoeba histolytica and rheumatic 
pain
7,8
. The decoction of the leaves is used 
for the treatment of malaria, intestinal worms, 
and amoebiasis 
9,10
. Recently Zirihi et al
11
 
have shown that the ethanol extract of M. 
morindoides exhibited good in vitro 
antimalarial activity against chloroquine-
resistant FcB1/Colombia strain of 
Plasmodium falciparum. 
 
Ten flavonoids which were identified as 








 have been isolated 
from the butanol and ethyl acetate fractions 
of the plant leaves.  In addition, a total of 
eight iridoid glycosides, among which are 
gaertneroside and gaertneric acid, 
methoxygaertneroside and 
epoxygaertneroside, were also isolated from 




M. morindoides is well known in the 
traditional medical practice of the west central 
part of Ivory Coast. It is commonly called 
Zêlékelé in the local language of ‘Bété’ and is 
used as an antifungal agent. The leaves of 
the plant are used in traditional medicine to 
treat diarrheoa. The present work was 
undertaken to investigate the potential in vivo 
antidiarrheal effect of the ethyl acetate extract 
of M. morindoides in various experimental 
models of diarrhoea in rats. 
 




The leaves of Morinda morindoides 
(Rubiaceae) were collected from Daloa 
(central west region of Ivory Coast) in June 
2006. The plant was identified and 
authenticated by Pr AKE ASSI, of the 
Department of Botany, University of Cocody. 
A voucher specimen (no17710) of the plant 
was deposited in the herbarium of the 
National Floristique Center of the University 
of Cocody-Abidjan. 
 
 Preparation of ethyl acetate extract 
 
The leaves of M. morindoides were cleaned 
of extraneous matter, air-dried at room 
temperature for 7 days and ground into a fine 
powder. The powder was mixed with distilled 
water (80 g of powder in 2 L of distilled water) 
for 24 h with constant stirring at 80°C. The 
extract was filtered twice through cotton wool, 
then through Whatman filter paper (No. 1). 
The filtrate was evaporated to dryness using 
a rotary evaporator (Buchi). Twenty five 
grams (25 g) of the dry aqueous extract was 
dissolved in 500 ml of ethanol and water 
(consisting of 350 ml of ethanol 96% and 150 
ml of distilled water) and after thorough 
mixing, the supernatant was evaporated 
using a rotary evaporator. Following the 
method of Guede-Guina et al
15
, 25 g of the 
dried extract was dispersed in 500 ml of a 
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solution (made up of 250 ml of ethyl acetate 
and 250 ml of distilled water), and mixed for 
24 h with constant stirring. From the two 
phases formed, the supernatant was 
evaporated using a rotary evaporator, and 
the resulting dry powder was taken as the 




Albino Wistar rats (weighing 150 - 200 g) of 
both sexes, were housed in standard metal 
cages. They were provided with food and 
water ad libitum, and allowed a one-week 
acclimatization period prior to the study. The 
equipment, handling and sacrificing of the 
animals were in accordance with the 
European Council legislation 87/609/EEC for 




Drug and chemicals 
 
Atropine sulphate and loperamide (Sigma 
Chemical Co, St Louis, Mo, USA), castor oil 
(Qualikems Fine Chemicals Pvt. Ltd, New 
Delhi, India), normal saline (NaCl 0.9%) and 
charcoal meal (10% activated charcoal in 100 
ml of 5% aqueous gum acacia) were used.  
 
Preliminary acute toxicity test  
 
The extract of M. morindoides was 
administered orally in doses of 125, 250, 500, 
1000, 2000, 4000 and 6000 mg/kg body 
weight to animal groups (one dose per 
group). Simultaneously, the control animals 
received normal saline (5ml/kg). The general 
signs and symptoms of toxicity, intake of food 
and water and mortality were recorded for a 
period of 48 h and then for a period of 14 
days. 
 
Castor oil-induced diarrhea in rats 
 
Twenty five (25) rats were fasted for 18 h and 
divided into five groups of five animals each. 
The plant extract (250, 500, and 1000 mg/kg 
body weight) were administered orally to 
groups 1, 2 and 3, respectively. The fourth 
group received normal saline (5 ml/kg body 
weight) and served as control, while the fifth 
group received the standard drug, loperamide 
(5 mg/kg body weight). One hour later, all the 
animals received 2 ml/rat of castor oil orally 
by gavage. The animals were kept in 
separate metabolic cages with a transparent 
plastic container beneath the cage to collect 
faeces
17
. The severity of diarrheoa was 
assessed each hour for 6 h. The total number 
of faeces (both diarrheal and non-diarrheal) 
expelled were compared with the control 
group. The total score of diarrheal faeces for 
the control group was considered as 100%. 
The results were expressed as a percentage 
of inhibition of diarrheoa.  
 
Gastrointestinal motility test 
 
The rats were divided into five groups of five 
animals each and fasted for 18 h but water 
was freely provided. The first group (control 
group) received orally normal saline (5 ml/kg 
body weight), while the second, third and 
fourth groups were given orally the plant 
extract in doses of 250, 500, and 1000 mg/kg 
body weight, respectively. The fifth group 
received orally the standard drug, atropine 
sulphate (5 mg/kg body weight). Thirty (30) 
min later, each animal was given 1 ml/rat of 
charcoal meal (10% activated charcoal in 5% 
gum acacia) via the oral route. All animals 
were sacrificed 30 min thereafter, and the 
distance covered by the charcoal meal in the 
intestine, from the pylorus to the caecum was 





Castor oil-induced enteropooling 
 
Intraluminal fluid accumulation was 
determined by the method of Robert et al
19
. 
Rats were divided into five groups of five 
animals each, one hour before oral 
administration of castor oil (2 ml/rat). Group 1 
received normal saline orally (5 ml/kg body 
weight), and served as the control. Group 2 
animals received loperamide (5mg/kg, oral) 
while groups 3, 4, and 5 received, by oral 
intubation, the extract of M. morindoides at 
doses of 250, 500 and 1000 mg/kg body 
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weight, respectively. Two hours later, the rats 
were sacrificed and the small intestine from 
the pylorus to the caecum was isolated. The 
intestinal contents were collected by milking 





Data were analyzed by one-way ANOVA 
followed by Dennett’s t-test using Instat
®
 
(Graph Pad software, U.S.A). At 95% 





Preliminary acute toxicity test 
 
It was observed that oral administration of the 
extract of M. morindoides to the rat up to 
6000 mg/kg neither showed mortality nor any 
apparent signs of weakness in the animals. 
 
Effect of M. morindoides extract on castor 
oil-induced diarrheoa 
 
In the castor oil-induced diarrheoa 
experiment, the extract of M. morindoides 
produced a marked antidiarrheal effect in the 
rats, as shown in Table 1. At doses of 250, 
500, and 1000 mg/kg, the extract significantly 
decreased (p < 0.01) the total number of wet 
faeces produced upon administration of 
castor oil (12.20 ± 1.06 at 250 mg/kg, 7.00 ± 
0.94 at 500 mg/kg and 6.20 ± 0.58 at 1000 
mg/kg) compared to the control group (18.6 ± 
0.74). The effect of the highest dose of the 
extract was similar to that of the standard 
drug, loperamide (5 mg/kg). 
 
Effect of M. morindoides extract on 
intestinal transit of charcoal meal 
 
The extract of M. morindoides decreased 
propulsion of charcoal meal in the rat 
gastrointestinal tract at oral doses of 250 - 
1000 mg/kg, compared with the control group 
that receiving normal saline (5 mg/kg). A 
similar reduction in the gastrointestinal transit 
of charcoal meal in rat was achieved with 
atropine sulphate (5 mg/kg). The results are 
shown in Table 2. 
 
Effect of extract of M. morindoides on 
castor oil-induced enteropooling 
 
Morinda morindoides extract significantly (P < 
0.01) inhibited castor oil-induced 
enteropooling in rats at oral doses of 500 and 
1000 mg/kg (Table 3). The intestinal fluid in 
control animals was 3.44 ± 0.36 ml. The 
inhibition of intestinal accumulation was 
24.41% (P < 0.01), 52.32% (P < 0.01) and 
61.04 % (P < 0.01) at doses of 250, 500, and 
1000 mg/kg of the extract, respectively. The 
standard drug, loperamide (5 mg/kg), also 
significantly inhibited (P < 0.01) intestinal fluid 




In the traditional medicine system, Morinda 
morindoides is used in the management of 
diarrheoa by traditional medicine practitioners 
in Ivory Coast. The present study sought to 
assess the antidiarrheal activity of the plant. 
Our results showed that the extract inhibited 
significantly (p < 0.01) castor oil-induced 
diarrheoa in rats. Several mechanisms had 
been previously proposed to explain the 
diarrheal effect of castor oil. These include 




 ATPase activity, 
thus reducing normal fluid absorption
20
, 









. Most recently nitric 
oxide has been claimed to contribute to the 
diarrheal effect of castor oil
24
. However, it is 
well documented that castor oil produces 
diarrhoea due to its most active component 
ricinoleic acid through a hypersecretory 
response
25,26
. Therefore it can be assumed 
that the antidiarrheal action of the extract was 
mediated by an antisecretory mechanism. 
This was also evident from the inhibition of 
castor oil-induced fluid accumulation by the 
extract. The results were comparable to 
those of the standard drug, loperamide.  
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Table 1: Effect of the extract of M. morindoides (MM-EA) on castor-oil induced diarrheoa in rat. 




Table 2: Effect of extract of M. morindoides (MM-EA) on the intestinal transit of charcoal meal in 
rat 
Treatment   Distance travelled by charcoal (%) Inhibition (%) 
Normal saline (5 mg/kg)  73.95 ± 3.55   
Atropine (5 mg/kg) 30.85 ± 1.69**  58.28 
MM-EA (250 mg/kg) 61.81 ± 3.45*  16.41 
MM-EA (500 mg/kg) 48.00 ± 2.59**  35.09 
MM-EA (1000 mg/kg) 35.62 ± 3.63**  51.83 
Values are expressed as mean ± S.E.M (n = 5) *P <0.05, **p < 0.0 1, when compared to the control 
 
Table 3: Effect of extract of M .morindoides (MM-EA) on castor-oil induced enteropooling in rat 
Treatment   
Volume of intestinal 
fluid (ml) 
Inhibition (%) 
Normal saline (5 mg/kg) + Castor oil (2 ml) 3.44 ± 0.36  
Loperamide (5 mg/kg) + Castor oil (2 ml) 1.40 ± 0.24** 59.30 
MM-EA (250 mg/kg) + Castor oil (2 ml) 2.60 ± 0.55 24.41 
MM-EA (500 mg/kg) + Castor oil (2 ml) 1.64 ± 0.20** 52.32 
MM-EA (1000 mg/kg) + Castor oil (2 ml) 1.34 ± 0.09** 61.04 
 
Values are expressed as mean ± S.E.M (n = 5). **P<0.01, when compared to the control 
       
Furthermore, the extract significantly reduced 
intestinal transit as evidenced by the decrease 
in the distance traveled by charcoal meal. 
These results also show that the extract 
suppressed the propulsion of charcoal meal 
thereby increasing the absorption of water and 
electrolytes. Antidiarrheal properties of 
medicinal plants were found to be due to 
tannins, flavonoids, alkaloids, saponins, 
reducing sugar, sterols and/or terpenes
27,28
. 
The antidiarrheal activity of flavonoids has 
been ascribed to their ability to inhibit 
intestinal motility and hydro-electrolytic 
secretions
29,30
 which are altered in this 
intestinal condition. In vitro and in vivo 
experiments have shown that flavonoids are 
Treatment 
  






Normal saline (5 mg/kg) +Castor oil (2 ml) 22.80 ± 0.86 18.6 ± 0.74  
Loperamide (5 mg/kg) + Castor oil (2 ml) 9.80 ±1.65** 5.20 ± 1.15** 72.04 
MM-EA (250 mg/kg)+ Castor oil (2 ml) 19.80 ± 0.73 12.20 ± 1.06** 34.40 
MM-EA (500 mg/kg) + Castor oil (2 ml) 16.40 ± 1.12** 7.00 ± 0.94** 62.36 
MM-EA (1000 mg/kg) + Castor oil (2 ml) 15.60 ± 1.80**   6.20 ± 0.58**  67.00 
Values are expressed as mean ± S.E.M (n = 5) **p < 0.0 1, when compared to the control 
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able to inhibit the intestinal secretory response 
induced by prostaglandins E2 
31
. In addition, 
flavonoids present antioxidant properties
32
 
which are presumed to be responsible for the 
inhibitory effects exerted upon several 




constituents may be responsible for the 
antidiarrheal activity of the ethyl acetate 




The results of this investigation revealed that 
M. morindoides contains pharmacologically 
active substances with antidiarrheal 
properties. These attributes may provide the 
rationale for the use of Morinda morindoides 
in diarrheoa management by traditional 
healers. Further research is needed to 
fractionate the ethyl acetate extract and 
isolate the molecule(s) responsible for the 
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